Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds.

Neklason DW, Thorpe BL, Ferrandez A, Tumbapura A, Boucher K, Garibotti G, Kerber RA, Solomon CH, Samowitz WS, Fang JC, Mineau GP, Leppert MF, Burt RW, Kuwada SK.

Am J Gastroenterol. 2008 Oct;103(10):2577-84. doi: 10.1111/j.1572-0241.2008.02019.x. Epub 2008 Jul 30.

2.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

3.

Colonoscopy: a review of its yield for cancers and adenomas by indication.

Rex DK.

Am J Gastroenterol. 1995 Mar;90(3):353-65. Review.

PMID:
7872270
4.

Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review.

Imperiale TF, Ransohoff DF.

Ann Intern Med. 2012 May 15;156(10):703-9. doi: 10.7326/0003-4819-156-10-201205150-00006. Review.

PMID:
22586009
5.

A systematic review and meta-analysis of familial colorectal cancer risk.

Johns LE, Houlston RS.

Am J Gastroenterol. 2001 Oct;96(10):2992-3003. Review.

PMID:
11693338
6.

Family history and the natural history of colorectal cancer: systematic review.

Henrikson NB, Webber EM, Goddard KA, Scrol A, Piper M, Williams MS, Zallen DT, Calonge N, Ganiats TG, Janssens AC, Zauber A, Lansdorp-Vogelaar I, van Ballegooijen M, Whitlock EP.

Genet Med. 2015 Sep;17(9):702-12. doi: 10.1038/gim.2014.188. Epub 2015 Jan 15. Review.

7.

How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?

Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, Brogyuk N, Bunganic B, Seifert B, Dusek L, Zavoral M.

World J Gastroenterol. 2016 Sep 28;22(36):8103-11. doi: 10.3748/wjg.v22.i36.8103. Review.

8.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review.

PMID:
27258162
9.

Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening.

Carethers JM.

Dig Dis Sci. 2015 Mar;60(3):711-21. doi: 10.1007/s10620-014-3443-5. Epub 2014 Dec 25. Review.

10.

Clinical and Biological Features of Interval Colorectal Cancer.

Lee YM, Huh KC.

Clin Endosc. 2017 May;50(3):254-260. doi: 10.5946/ce.2016.115. Epub 2017 Mar 21. Review.

Supplemental Content

Support Center